Stoneridge Investment Partners, LLC v. Scientific-Atlanta, Inc., 552 U.S. 148 (2008) (U.S. Supreme Court)
Stoneridge Investment Partners v. Scientific-Atlanta is a cornerstone Supreme Court decision narrowing the scope of private securities fraud actions under Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5.
Can investors maintain a private Section 10(b)/Rule 10b-5 action against secondary actors (such as a supplier or customer) for participating in transactions that enabled an issuer's misstatements, when the secondary actors' deceptive conduct was not publicly disclosed and thus not relied upon by investors?
Section 10(b) of the Securities Exchange Act and Rule 10b-5 prohibit the use of any manipulative or deceptive device or contrivance in connection with the purchase or sale of securities. To state a private Rule 10b-5 claim, a plaintiff must plead and ultimately prove: (1) a material misrepresentation or omission by the defendant; (2) scienter; (3) a connection with the purchase or sale of a security; (4) reliance upon the defendant's deceptive conduct; (5) economic loss; and (6) loss causation. Reliance ensures the requisite causal connection between the defendant's conduct and the plaintiff's injury and may be presumed under Basic's fraud-on-the-market theory only for public misstatements by the defendant or for omissions where the defendant had a duty to disclose. Central Bank holds that private plaintiffs may not recover for aiding and abetting; liability must be primary as to each defendant, and cannot be expanded by recharacterizing aiding-and-abetting as "scheme liability."
No. Investors cannot maintain a private Rule 10b-5 action against the vendors because the investors did not rely on the vendors' own deceptive conduct; their acts were not disclosed to the market and any causal link to the investors' decision to trade was too remote. Extending liability would contravene the reliance requirement and effectively revive aiding-and-abetting liability barred in private suits by Central Bank.
Stoneridge firmly cabins private Rule 10b-5 liability by emphasizing reliance and limiting scheme liability against secondary actors whose conduct was not publicly attributed to them. It complements Central Bank's bar on aiding-and-abetting in private suits and shaped later doctrine, including Janus's definition of who "makes" a statement. For litigants, it underscores that each defendant's own public deceptive conduct must be the object of investor reliance. For transactional lawyers and compliance professionals, it reduces exposure for routine business partners of issuers while still leaving space for SEC enforcement against aiders and abettors. For students, the case is a key study in elements of a 10b-5 claim, the role of implied rights of action, and how policy concerns influence statutory interpretation in securities regulation.